Clinical Trial Update: Theranostic Guided Riboflavin/UV-A Corneal Cross-linking [NA]

View source ↗

Summary

Clinical trial NCT05457647 evaluated theranostic guided riboflavin/UV-A corneal cross-linking for keratoconus; the study is completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Riboflavin ophthalmic solution (riboflavin)

Snippet

Sponsor: Regensight | Conditions: Keratoconus | NA | Status: COMPLETED | Results posted: 2025-02-11